InvestorsHub Logo
Followers 10
Posts 997
Boards Moderated 0
Alias Born 01/17/2005

Re: None

Friday, 10/25/2013 1:43:30 PM

Friday, October 25, 2013 1:43:30 PM

Post# of 18483
"Extracorporeal Removal of Microvesicular Particles" -from Oct, 2012. With all the tremendous research in the field of cancer being directed towards exosomes, one wonders what is the worth of this patent by itself?

http://www.prnewswire.com/news-releases/aethlon-medical-announces-issuance-of-cancer-therapy-patent-175781691.html

"The patent entitled "Extracorporeal Removal of Microvesicular Particles," provides Aethlon Medical the exclusive right to remove immune suppressive microvesicular particles, which include but are not limited to exosomes from the circulation of treated patients. A therapy able to inhibit or reduce the presence of cancer-secreted exosomes would address a significant unmet medical need in the effort to combat cancer."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News